ClearBridge International Growth ADR Strategy exits Linde, adds Roche in Q4 2025
2026-02-04 13:32:33 ET
More on related tickers
- Trane Technologies: Upgrade To Buy On Cheaper Valuation And Better Fundamentals
- Roche Holding AG (RHHBY) Q4 2025 Earnings Call Transcript
- Linde Q4 2025 Earnings Preview
- Genentech in up to $1.7B RNAi licensing deal with SanegeneBio
Read the full article on Seeking Alpha
For further details see:
ClearBridge International Growth ADR Strategy exits Linde, adds Roche in Q4 2025NASDAQ: BYDDF
BYDDF Trading
0.0% G/L:
$12.43 Last:
26,863 Volume:
$12.45 Open:



